Sort   by:  
 Page size 
UnknownThe impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
Not available
S-EPMC9296648 | biostudies-literature
UnknownTime to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.
Not available
S-EPMC4855631 | biostudies-literature
UnknownHPV Serology Testing Confirms High HPV Immunisation Coverage in England.
Not available
S-EPMC4784902 | biostudies-literature
UnknownComparing the performance of six human papillomavirus tests in a screening population.
Not available
S-EPMC3590662 | biostudies-literature
UnknownEffect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.
Not available
S-EPMC3251847 | biostudies-literature
Unknownp63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.
Not available
S-EPMC3600906 | biostudies-literature
UnknownA comparison of COVID-19 incidence rates across six European countries in 2021.
Not available
S-EPMC10557383 | biostudies-literature
UnknownPopulation-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.
Not available
S-EPMC5038419 | biostudies-literature
UnknownPrognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.
Not available
S-EPMC3304411 | biostudies-literature
UnknownExtension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.
Not available
S-EPMC9153243 | biostudies-literature
Sort   by:  
 Page size